Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: Randomised controlled trial

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Gágyor, Ildikó ^a   Bleidorn, Jutta ^b   Kochen, Michael M ^c   Schmiemann, Guido ^d   Wegscheider, Karl ^e   Hummers Pradier, Eva ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF BREMEN   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FOSFOMYCIN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; FOSFOMYCIN; HUMANS; IBUPROFEN; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84953861786     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h6544     Document Type: Article

References (38)

1. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012;366: 1028-37. doi:10.1056/NEJMcp1104429 22417256
2. Ong DS, Kuyvenhoven MM, van Dijk L, Verheij TJ. Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs. J Antimicrob Chemother 2008;62: 587-92. doi:10.1093/jac/dkn230 18544602
3. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.
4. World Health Organization. Antimicrobial resistance: Global Report on Surveillance 2014 2014. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf.
5. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014;28: 1-13. doi:10.1016/j.idc.2013.09.003 24484571
6. Donnan PT, Wei L, Steinke DT. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data. BMJ 2004;328: 1297. doi:10.1136/bmj.328.7451.1297 15166067
7. Epidemiology, diagnostics, therapy and management of uncomplicated bacterial community acquired urinary tract infection in adults: German S3-Guideline 2010. http://www.awmf.org/leitlinien/detail/ll/043-044.html.
8. The Dutch College of General Practitioners. Urineweginfecties M05 2013. https://www.nhg.org/standaarden/samenvatting/urineweginfecties.
9. Christiaens TCM, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52: 729-34. 12236276
10. Bleidorn J, Gágyor I, Kochen MM, Wegscheider K, Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - results of a randomized controlled pilot trial. BMC Med 2010;8: 30. doi:10.1186/1741-7015-8-30 20504298
11. Little P, Moore MV, Turner S. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ 2010;340: c199. doi:10.1136/bmj.c199 20139214
12. Patrick DM, Hutchinson J. Antibiotic use and population ecology: how you can reduce your "resistance footprint". CMAJ 2009;180: 416-21. doi:10.1503/cmaj.080626 19221355
13. Butler CC, Dunstan F, Heginbothom M. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 2007;57: 785-92. 17925135
14. Gyssens IC. Antibiotic policy. Int J Antimicrob Agents 2011;38(Suppl): 11-20. doi:10.1016/j.ijantimicag.2011.09.002 22018989
15. Gottesman BS, Carmeli Y, Shitrit P, Chowers M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009;49: 869-75. doi:10.1086/605530 19686074
16. Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 2004;36: 296-301. doi:10.1080/00365540410019642 15198188
17. Knottnerus BJ, Geerlings SE, Moll van Charante EP, ter Riet G. Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study. BMC Fam Pract 2013;14: 71. doi:10.1186/1471-2296-14-71 23721260
18. Leydon GM, Turner S, Smith H, Little PUTIS team. Women's views about management and cause of urinary tract infection: qualitative interview study. BMJ 2010;340: c279. doi:10.1136/bmj. c279 20139217
19. Willems CS, van den Broek D'Obrenan J, Numans ME, Verheij TJ, van der Velden AW. Cystitis: antibiotic prescribing, consultation, attitudes and opinions. Fam Pract 2014;31: 149-55. doi:10.1093/fampra/cmt077 24317602
20. Gágyor I, Hummers-Pradier E, Kochen MM, Schmiemann G, Wegscheider K, Bleidorn J. Immediate versus conditional treatment of uncomplicated urinary tract infection-a randomized-controlled comparative effectiveness study in general practices. BMC Infect Dis 2012;12: 146. doi:10.1186/1471-2334-12-146 22742538
21. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015;350: h2147. doi:10.1136/bmj.h2147 25956159
22. Mauch H, Podbielski A, Herrmann M, Gatermann SG, Fönfstöck R, Handrick W. Harnwegsinfektionen: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. 2nd ed. Urban & Fischer Verlag/Elsevier GmbH 2005.
23. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338: b1374. doi:10.1136/bmj. b1374 19416992
24. Linde M, Mellberg A, Dahlöf C. The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan. Cephalalgia 2006;26: 712-21. doi:10.1111/j.1468-2982.2006.01097.x 16686911
25. Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs 2009;69: 1205-16. doi:10.2165/00003495-200969090-00005 19537837
26. Wild DJ, Clayson DJ, Keating K, Gondek K. Validation of a patientadministered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes 2005;3: 42. doi:10.1186/1477-7525-3-42 16022727
27. Julious SA. Sample sizes for clinical trials with normal data. Stat Med 2004;23: 1921-86. doi:10.1002/sim.1783 15195324
28. Vik I, Bollestad M, Grude N. Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol. BMC Infect Dis 2014;14: 693. doi:10.1186/s12879-014-0693-y 25516016
29. van Pinxteren B, Knottnerus BJ, Geerlings SE. NHG-Standaard Urineweginfecties (derde herziening). Huisarts Wet 2013;56: 270-80.
30. Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 2009;58: 91-102. doi:10.1016/j.jinf.2008.12.009. 19195714
31. Obad J, Šuškovic J, Kos B. Antimicrobial activity of ibuprofen: new perspectives on an "Old" non-antibiotic drug. Eur J Pharm Sci 2015;71: 93-8. doi:10.1016/j.ejps.2015.02.011 25708941
32. Cai T, Mazzoli S, Mondaini N. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?Clin Infect Dis 2012;55: 771-7. doi:10.1093/cid/cis534 22677710
33. Scottish Intercollegiate Guidelines Network. Management of suspected bacterial urinary tract infection in adults 2012. www.sign. ac.uk/pdf/sign88.pdf.
34. Giesen LG, Cousins G, Dimitrov BD, van de Laar FA, Fahey T. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract 2010;11: 78. doi:10.1186/1471-2296-11-78 20969801
35. Baerheim A, Digranes A, Hunskaar S. Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. Scand J Prim Health Care 1999;17: 170-3. doi:10.1080/028134399750002593 10555247
36. Bates J, Thomas-Jones E, Pickles T. Point of care testing for urinary tract infection in primary care (POETIC): protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT™ informed management of uncomplicated UTI in primary care. BMC Fam Pract 2014;15: 187. doi:10.1186/s12875-014-0187-4 25425162
37. Donovan JL, de Salis I, Toerien M, Paramasivan S, Hamdy FC, Blazeby JM. The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials. J Clin Epidemiol 2014;67: 912-20. doi:10.1016/j. jclinepi.2014.03.010 24811157
38. Little P, Stuart B, Hobbs FDDESCARTE investigators. Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study. Lancet Infect Dis 2014;14: 213-9. doi:10.1016/S1473-3099(13)70294-9 24440616